Drug:
Reaction: DRY SKIN
20250101 - 20251231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 25052435 |
US |
||
Dry skin, |
||||
| 502 | 25052440 |
US |
||
Skin burning sensation, Acne, Erythema, Skin irritation, Dry skin, Rash macular, |
||||
ADAPALENE, SALICYLIC ACID, SALICYLIC ACID, |
||||
| 503 | 25052445 |
US |
||
Dry skin, Rash, Drug ineffective, |
||||
ADAPALENE, |
||||
| 504 | 25052446 |
US |
||
Skin burning sensation, Skin irritation, Hypersensitivity, Dry skin, Skin exfoliation, Inappropriate schedule of product administration, Underdose, |
||||
ADAPALENE, ADAPALENE, ADAPALENE, ADAPALENE, TESTOSTERONE, TESTOSTERONE,, PROGESTERONE, ESCITALOPRAM, IRON, |
||||
| 505 | 25052448 |
US |
||
Dry skin, |
||||
ADAPALENE, |
||||
| 506 | 25052457 |
US |
||
Skin burning sensation, Skin irritation, Pain of skin, Dry skin, |
||||
ADAPALENE, |
||||
| 507 | 25052462 |
US |
||
Skin burning sensation, Erythema, Pruritus, Rash, Dry skin, Skin irritation, |
||||
ADAPALENE, |
||||
| 508 | 25052464 |
US |
||
Dry skin, Erythema, |
||||
ADAPALENE, |
||||
| 509 | 25052469 |
US |
||
Skin burning sensation, Erythema, Dry skin, |
||||
ADAPALENE, |
||||
| 510 | 25052475 |
US |
||
Pruritus, Rash, Dry skin, |
||||
ADAPALENE, |
||||
| 511 | 25052477 |
US |
||
Sensitive skin, Dry skin, |
||||
ADAPALENE, |
||||
| 512 | 25052484 |
US |
||
Skin burning sensation, Dry skin, Erythema, Drug ineffective, |
||||
ADAPALENE, |
||||
| 513 | 25052489 |
US |
||
Dry skin, Skin burning sensation, Erythema, Skin irritation, |
||||
ADAPALENE, |
||||
| 514 | 25052493 |
US |
||
Dry skin, |
||||
ADAPALENE, |
||||
| 515 | 25052494 |
US |
||
Dry skin, |
||||
ADAPALENE, |
||||
| 516 | 25052501 |
US |
||
Dry skin, Skin irritation, Product use issue, |
||||
ADAPALENE, |
||||
| 517 | 25052503 |
US |
||
Dry skin, Drug ineffective, Inappropriate schedule of product administration, Overdose, |
||||
ADAPALENE, |
||||
| 518 | 25052504 |
US |
||
Dry skin, |
||||
ADAPALENE, |
||||
| 519 | 25052511 |
US |
||
Dry skin, Swelling face, Pain of skin, |
||||
ADAPALENE, SALICYLIC ACID, |
||||
| 520 | 25052513 |
US |
||
Dry skin, Skin burning sensation, |
||||
ADAPALENE, SALICYLIC ACID, |
||||
| 521 | 25052788 |
US |
77 | 1 |
Rash pruritic, Dry skin, Fatigue, Dehydration, Pruritus, Injection site pain, Inappropriate schedule of product administration, |
||||
DUPILUMAB, BUPROPION HYDROCHLORIDE, GABAPENTIN, PROPRANOLOL HYDROCHLORIDE, |
||||
| 522 | 25052821 |
US |
61 | 1 |
Dry skin, Scratch, Pruritus, |
||||
DUPILUMAB, RUXOLITINIB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LORATADINE, PSEUDOEPHEDRINE SULFATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, METHOCARBAMOL, METHOCARBAMOL TABLETS, |
||||
| 523 | 25052846 |
US |
2 | |
Dry skin, Eye pruritus, Dry eye, Arthralgia, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 524 | 25052855 |
US |
59 | 2 |
Dyspepsia, Constipation, Muscle spasms, Abdominal pain, Influenza, Asthma, Impaired quality of life, Eye irritation, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, TIRZEPATIDE, ALBUTEROL SULFATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, LISINOPRIL, LORAZEPAM, PREDNISONE, ROSUVASTATIN, SERTRALINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 525 | 25052989 |
US |
18 | 1 |
Injury, Pain, Pallor, Dry skin, Eczema, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 526 | 25052990 |
US |
1 | |
Dry skin, Stress, Bursitis, Pruritus, Headache, Incorrect dose administered, |
||||
DUPILUMAB, CARVEDILOL, APIXABAN, FUROSEMIDE, LISINOPRIL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
| 527 | 25053014 |
US |
2 | |
Dry skin, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, VITAMIN C, VENLAFAXINE HYDROCHLORIDE, CALCIUM, |
||||
| 528 | 25053024 |
US |
59 | 2 |
Eye swelling, Ocular hyperaemia, Eye pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 529 | 25053062 |
US |
27 | 2 |
Dry skin, Skin haemorrhage, Condition aggravated, Skin fissures, |
||||
DUPILUMAB, DUPILUMAB, IRON, |
||||
| 530 | 25053103 |
US |
31 | 2 |
Dry skin, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 531 | 25053121 |
US |
2 | |
Dry skin, Pruritus, |
||||
DUPILUMAB, AMLODIPINE, NADOLOL, ERGOCALCIFEROL, |
||||
| 532 | 25053151 |
US |
63 | 2 |
Skin disorder, Dry skin, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, LISINOPRIL, LEVOTHYROXINE SODIUM, |
||||
| 533 | 25053181 |
US |
69 | 2 |
Dry skin, Skin exfoliation, Pruritus, |
||||
DUPILUMAB, RUXOLITINIB, |
||||
| 534 | 25053246 |
US |
47 | 2 |
Dry skin, Skin exfoliation, Pruritus, |
||||
DUPILUMAB, |
||||
| 535 | 25053364 |
US |
2 | |
Blister, Skin burning sensation, Rash macular, Dry skin, Fatigue, Product use in unapproved indication, |
||||
DUPILUMAB, TOPIRAMATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, HYDROXYCHLOROQUINE, CLONAZEPAM, ROSUVASTATIN, LEVOTHYROXINE SODIUM, |
||||
| 536 | 25053372 |
US |
55 | 2 |
Dermatitis atopic, Dry skin, Skin exfoliation, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 537 | 25053419 |
US |
27 | 2 |
Dry skin, Rash, |
||||
DUPILUMAB, |
||||
| 538 | 25053495 |
US |
16 | 2 |
Dry skin, Dyspnoea, Ocular discomfort, Skin exfoliation, Pruritus, |
||||
DUPILUMAB, |
||||
| 539 | 25053501 |
US |
58 | 1 |
Dry skin, Skin haemorrhage, Skin fissures, |
||||
DUPILUMAB, |
||||
| 540 | 25053534 |
US |
51 | 1 |
Dry skin, |
||||
BELUMOSUDIL, LISINOPRIL, PREDNISONE, MAGNESIUM OXIDE, |
||||
| 541 | 25053542 |
US |
1 | |
Dry skin, Skin exfoliation, Skin exfoliation, |
||||
DUPILUMAB, BENRALIZUMAB, LEVOCETIRIZINE DIHYDROCHLORIDE, DORZOLAMIDE, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM, LOSARTAN, NIFEDIPINE, ROSUVASTATIN, |
||||
| 542 | 25053551 |
US |
46 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 543 | 25053617 |
US |
48 | 1 |
Pruritus, Eczema, Dry skin, Swelling, Incorrect dose administered, Incorrect route of product administration, |
||||
DUPILUMAB, |
||||
| 544 | 25053620 |
US |
19 | 1 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 545 | 25053634 |
US |
15 | 2 |
Skin irritation, Erythema, Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 546 | 25053660 |
US |
73 | 1 |
Dry skin, Sleep disorder, Pruritus, |
||||
DUPILUMAB, |
||||
| 547 | 25053710 |
US |
28 | 1 |
Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 548 | 25053714 |
US |
26 | 1 |
Dry skin, Eczema, Pruritus, Eye pruritus, Injection site pain, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 549 | 25053735 |
US |
65 | 2 |
Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 550 | 25053785 |
US |
2 | |
Dermatitis atopic, Dry skin, |
||||
DUPILUMAB, |
||||
| 551 | 25053795 |
US |
28 | 1 |
Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 552 | 25053820 |
US |
73 | 1 |
Pruritus, Rash, Hyperkeratosis, Scratch, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 553 | 25053846 |
US |
33 | 1 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 554 | 25053856 |
US |
68 | 2 |
Dry skin, Skin exfoliation, Injection site pain, |
||||
DUPILUMAB, |
||||
| 555 | 25053862 |
US |
8 | 1 |
Dry skin, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 556 | 25053876 |
US |
24 | 1 |
Eczema, Dry skin, |
||||
DUPILUMAB, |
||||
| 557 | 25053891 |
US |
90 | 2 |
Dry skin, Rhinorrhoea, |
||||
DUPILUMAB, |
||||
| 558 | 25053914 |
US |
46 | 2 |
Dermatitis atopic, Skin fissures, Pain of skin, Skin erosion, Hypoaesthesia, Skin exfoliation, Erythema, Dry skin, |
||||
DUPILUMAB, IRON, ERGOCALCIFEROL, VITAMIN C, LISDEXAMFETAMINE DIMESYLATE, |
||||
| 559 | 25053935 |
US |
24 | 2 |
Dry skin, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 560 | 25054021 |
US |
26 | 1 |
Psoriasis, Dry skin, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 561 | 25054022 |
US |
42 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 562 | 25054043 |
US |
11 | 2 |
Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 563 | 25054068 |
US |
16 | 2 |
Dry skin, Skin exfoliation, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 564 | 25054073 |
US |
2 | |
Dry skin, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 565 | 25054078 |
US |
2 | |
Rash macular, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 566 | 25054102 |
US |
22 | 2 |
Dry skin, Skin fissures, Muscle spasms, Pruritus, |
||||
DUPILUMAB, |
||||
| 567 | 25054121 |
US |
58 | 2 |
Fatigue, Dry skin, Dry eye, Pruritus, Injection site swelling, Injection site pain, |
||||
DUPILUMAB, |
||||
| 568 | 25054130 |
US |
26 | 1 |
Dermatitis atopic, Pruritus, Dry skin, Rash, |
||||
DUPILUMAB, |
||||
| 569 | 25054238 |
US |
72 | 2 |
Rash, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 570 | 25054312 |
US |
2 | |
Dry skin, Ocular hyperaemia, Vaginal discharge, |
||||
DUPILUMAB, |
||||
| 571 | 25054361 |
US |
16 | 2 |
Pruritus, Drug ineffective, Skin haemorrhage, Dry skin, |
||||
DUPILUMAB, |
||||
| 572 | 25054373 |
US |
80 | 2 |
Pruritus, Dry skin, Skin exfoliation, Decreased interest, Depressed mood, Disturbance in attention, |
||||
DUPILUMAB, QUETIAPINE, |
||||
| 573 | 25054388 |
US |
2 | |
Dry skin, Skin fissures, Condition aggravated, Skin haemorrhage, Condition aggravated, |
||||
DUPILUMAB, |
||||
| 574 | 25054418 |
US |
2 | 1 |
Dry skin, Skin discolouration, Pruritus, |
||||
DUPILUMAB, |
||||
| 575 | 25054430 |
US |
60 | 2 |
Dry skin, Skin haemorrhage, Skin weeping, Skin fissures, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 576 | 25054528 |
US |
19 | 2 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 577 | 25054538 |
US |
1 | |
Dermatitis atopic, Dry skin, Rash, Pruritus, |
||||
DUPILUMAB, |
||||
| 578 | 25054555 |
US |
38 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 579 | 25045081 |
US |
20 | 2 |
Erythema, Skin burning sensation, Dry skin, |
||||
IXEKIZUMAB, DESONIDE, |
||||
| 580 | 25045133 |
US |
2 | |
Surgery, Ankylosing spondylitis, Blood test abnormal, Headache, Dry skin, Pruritus, Tinea pedis, Nail disorder, |
||||
BIMEKIZUMAB, |
||||
| 581 | 25045187 |
US |
79 | 2 |
Dry skin, |
||||
ABATACEPT, ABATACEPT, |
||||
| 582 | 25045198 |
GB |
44 | 1 |
Dry skin, |
||||
| 583 | 25047045 |
US |
80 | 2 |
Cervical spinal stenosis, Haemolysis, Neuropathy peripheral, Transient ischaemic attack, Sarcopenia, Iron metabolism disorder, Dry skin, Erythema, Ecchymosis, Raynaud^s phenomenon, Skin lesion, Livedo reticularis, Cardiac murmur, Varicose vein, Fatigue, Sleep disorder, Rhinorrhoea, Upper-airway cough syndrome, Dry mouth, Mouth ulceration, Dysphonia, Lymphadenopathy, Dysphagia, Skin hypopigmentation, Increased tendency to bruise, Alopecia, Temperature intolerance, Dry eye, Dyspnoea exertional, Constipation, Dyspepsia, Abdominal distension, Nocturia, Anxiety, Affect lability, Leukocytosis, Blood creatine phosphokinase decreased, Red blood cell sedimentation rate abnormal, Upper respiratory tract infection, Bronchospasm, |
||||
APREMILAST, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ETANERCEPT, MOMETASONE FUROATE, MAGNESIUM OXIDE, CELECOXIB, LORATADINE, LORATADINE ORAL, ABATACEPT, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LEVOTHYROXINE, ALBUTEROL SULFATE, ERGOCALCIFEROL, METHYLPREDNISOLONE, DICLOFENAC, DICLOFENAC SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, OXYCODONE, GABAPENTIN, AMOXICILLIN AND CLAVULANATE POTASSIUM, BACLOFEN, MONTELUKAST, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, EMPAGLIFLOZIN, LIRAGLUTIDE, LIRAGLUTIDE, DICLOFENAC SODIUM, COLCHICINE, PROPRANOLOL HYDROCHLORIDE, RIMEGEPANT SULFATE, UBROGEPANT, LEFLUNOMIDE, HYDROXYCHLOROQUINE SULFATE, AZATHIOPRINE, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, METHOTREXATE, TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION, |
||||
| 584 | 25047191 |
US |
59 | 1 |
Pain, Skin tightness, Dry skin, Impaired work ability, Insomnia, |
||||
DAROLUTAMIDE, RELUGOLIX, RELUGOLIX, AMLODIPINE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 585 | 25047460 |
US |
78 | 2 |
Femur fracture, Fall, Dry skin, Pruritus, |
||||
DUPILUMAB, EVOLOCUMAB, OIL, BIOTIN, HAIR, ERGOCALCIFEROL, CALCIUM, MUPIROCIN, MUPIROCIN CALCIUM, FLUOROURACIL, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, PROGESTERONE, LIOTHYRONINE SODIUM, LISINOPRIL, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, PRASTERONE, GABAPENTIN, VALACYCLOVIR HYDROCHLORIDE, DICLOFENAC SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 586 | 25039240 |
GB |
44 | 1 |
Dry skin, |
||||
| 587 | 25039563 |
US |
42 | 2 |
Feeling cold, Blood pressure increased, Nausea, Muscle spasms, Dry skin, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, TEPROTUMUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 588 | 25039864 |
ZA |
50 | 2 |
Dyspepsia, Dry skin, Pruritus, |
||||
UPADACITINIB, |
||||
| 589 | 25040236 |
US |
||
Dry skin, Skin exfoliation, |
||||
BUROSUMAB, BUROSUMAB, WARFARIN, RISPERIDONE, SUVOREXANT, |
||||
| 590 | 25040773 |
FR |
71 | 2 |
Fatigue, Nausea, Dry skin, Agranulocytosis, Thrombocytopenia, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CAPECITABINE, EZETIMIBE, BISOPROLOL FUMARATE, APIXABAN, PANCRELIPASE, CAPECITABINE, CAPECITABINE, |
||||
| 591 | 25041242 |
US |
1 | |
Seizure, Eye operation, Dry skin, |
||||
FENFLURAMINE, FENFLURAMINE, |
||||
| 592 | 25042576 |
US |
90 | 2 |
Dialysis, Condition aggravated, Dry skin, Cerebrovascular accident, Pruritus, Discomfort, Musculoskeletal stiffness, Pain, Skin plaque, |
||||
ADALIMUMAB, |
||||
| 593 | 25042625 |
FI |
32 | 2 |
Depression, Mucosal dryness, Suicidal ideation, Dry skin, Cognitive disorder, |
||||
ISOTRETINOIN, |
||||
| 594 | 25042954 |
RS |
51 | 1 |
Musculoskeletal toxicity, Skin toxicity, Muscle spasms, Myalgia, Muscle rupture, Arthralgia, Gait disturbance, Pain in extremity, Rash, Pruritus, Alopecia, Dry skin, Fatigue, |
||||
NILOTINIB, |
||||
| 595 | 25043036 |
US |
11 | 1 |
Respiratory syncytial virus infection, Sleep disorder due to a general medical condition, Erythema, Eczema, Pruritus, Skin fissures, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, |
||||
| 596 | 25045686 |
60 | 2 | |
Abdominal pain upper, Dry skin, Nasal ulcer, Rash macular, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 597 | 25034241 |
US |
70 | 2 |
Arthropod bite, Dry skin, Pruritus, Ocular hyperaemia, Dry eye, |
||||
DUPILUMAB, HYDROXYZINE, LISINOPRIL, PREGABALIN, ERGOCALCIFEROL, |
||||
| 598 | 25034250 |
US |
60 | |
Skin disorder, Pruritus, Skin discomfort, Dry skin, Depressed mood, Erythema, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 599 | 25034310 |
CA |
54 | 2 |
Intestinal obstruction, Hypothyroidism, Anxiety, Thyroid disorder, Nasal pruritus, Dry skin, Hypersensitivity, Hepatic enzyme increased, Blood thyroid stimulating hormone increased, Eye pruritus, Pruritus, Drug ineffective, |
||||
OBETICHOLIC ACID, OBETICHOLIC ACID, |
||||
| 600 | 25034431 |
US |
2 | |
Skin atrophy, Skin fissures, Dry skin, Pruritus, Arthralgia, Product dose omission issue, |
||||
DUPILUMAB, MOMETASONE, MOMETASONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28